Z W Zhang1, S E Patchett, D Perrett, P Domizio, M J Farthing. 1. Digestive Diseases Research Centre, St Bartholomew's and the Royal and London School of Medicine and Dentistry, London, UK. zwzhang@mds.qmw.ac.uk
Abstract
OBJECTIVE: The effects of Helicobacter pylori infection and its associated gastric histology on alpha-tocopherol and beta-carotene concentrations in serum, gastric juice and antral mucosa were investigated in patients undergoing routine gastroscopy for investigation of dyspepsia. METHOD: Eighty-six patients were studied. High-performance liquid chromatography was used to measure alpha-tocopherol and beta-carotene concentrations. H. pylori infection was assessed by histology, bacterial culture, rapid urease test and serology. RESULTS: No obvious association was found between age, sex, smoking or endoscopic diagnosis and alpha-tocopherol or beta-carotene concentrations in serum, gastric juice and antral mucosa. However, alcohol drinkers had significantly lower antral mucosal and gastric juice beta-carotene concentrations compared to non-drinkers. Gastric juice beta-carotene concentration was markedly lower in patients infected with H. pylori than uninfected controls (2.9 nmol/l (interquartile range 0.3-4.3) versus 4.6 nmol/l (interquartile range 3.5-7.6), P = 0.01), but there was no significant difference in serum or gastric mucosal beta-carotene concentrations between the two patient groups. The presence of gastric atrophy and intestinal metaplasia was significantly associated with reduced mucosal alpha-tocopherol and beta-carotene concentrations. Furthermore, antral mucosal alpha-tocopherol concentrations decreased progressively as antral mucosal histology changed from normal to chronic gastritis alone and finally to atrophy and intestinal metaplasia. CONCLUSION: Gastric alpha-tocopherol and beta-carotene concentrations are affected by H. pylori-associated gastric histological changes, and these findings suggest that H. pylori infection may not only impair the protective role of vitamin C, but also of alpha-tocopherol and beta-carotene in the stomach.
OBJECTIVE: The effects of Helicobacter pylori infection and its associated gastric histology on alpha-tocopherol and beta-carotene concentrations in serum, gastric juice and antral mucosa were investigated in patients undergoing routine gastroscopy for investigation of dyspepsia. METHOD: Eighty-six patients were studied. High-performance liquid chromatography was used to measure alpha-tocopherol and beta-carotene concentrations. H. pyloriinfection was assessed by histology, bacterial culture, rapid urease test and serology. RESULTS: No obvious association was found between age, sex, smoking or endoscopic diagnosis and alpha-tocopherol or beta-carotene concentrations in serum, gastric juice and antral mucosa. However, alcohol drinkers had significantly lower antral mucosal and gastric juice beta-carotene concentrations compared to non-drinkers. Gastric juice beta-carotene concentration was markedly lower in patients infected with H. pylori than uninfected controls (2.9 nmol/l (interquartile range 0.3-4.3) versus 4.6 nmol/l (interquartile range 3.5-7.6), P = 0.01), but there was no significant difference in serum or gastric mucosal beta-carotene concentrations between the two patient groups. The presence of gastric atrophy and intestinal metaplasia was significantly associated with reduced mucosal alpha-tocopherol and beta-carotene concentrations. Furthermore, antral mucosal alpha-tocopherol concentrations decreased progressively as antral mucosal histology changed from normal to chronic gastritis alone and finally to atrophy and intestinal metaplasia. CONCLUSION: Gastric alpha-tocopherol and beta-carotene concentrations are affected by H. pylori-associated gastric histological changes, and these findings suggest that H. pyloriinfection may not only impair the protective role of vitamin C, but also of alpha-tocopherol and beta-carotene in the stomach.
Authors: Meira Epplein; Lisa B Signorello; Wei Zheng; Qiuyin Cai; Margaret K Hargreaves; Angelika Michel; Michael Pawlita; Jay H Fowke; Pelayo Correa; William J Blot Journal: Cancer Prev Res (Phila) Date: 2011-03-24
Authors: Carlos Vílchez; Eduardo Forján; María Cuaresma; Francisco Bédmar; Inés Garbayo; José M Vega Journal: Mar Drugs Date: 2011-03-03 Impact factor: 5.118
Authors: M Jenab; E Riboli; P Ferrari; M Friesen; J Sabate; T Norat; N Slimani; A Tjønneland; A Olsen; K Overvad; M-C Boutron-Ruault; F Clavel-Chapelon; H Boeing; M Schulz; J Linseisen; G Nagel; A Trichopoulou; A Naska; E Oikonomou; F Berrino; S Panico; D Palli; C Sacerdote; R Tumino; P H Peeters; M E Numans; H B Bueno-de-Mesquita; F L Büchner; E Lund; G Pera; M D Chirlaque; M-J Sánchez; L Arriola; A Barricarte; J R Quirós; I Johansson; A Johansson; G Berglund; S Bingham; K-T Khaw; N Allen; T Key; F Carneiro; V Save; G Del Giudice; M Plebani; R Kaaks; C A Gonzalez Journal: Br J Cancer Date: 2006-07-11 Impact factor: 7.640
Authors: Vladimir Bespalov; Alexander Sherbakov; Viktor Novik; Valentin Kalinovsky; Kamran Shamsi; Vagif Soultanov Journal: Evid Based Complement Alternat Med Date: 2016-11-28 Impact factor: 2.629
Authors: Le Hong Phuoc; Khanpaseuth Sengngam; Toshio Ogawa; Nlandu Roger Ngatu; Shunya Ikeda; Tran Hieu Hoc; Pham Van Phu; Dinh Thi Minh; Le Tran Ngoan Journal: Asian Pac J Cancer Prev Date: 2020-07-01